drugset / Trial / NCT05106179

The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma

NCT05106179

Phase 4 Unknown 1000 enrolled Center for Vascular Pathology, Moscow
Non-randomizedParallel-groupOpen-labelTreatment

Summary

Spinal hemangioma is one of the most common benign vertebral tumours. Being mostly asymptomatic, it is still associated with a pain syndrome especially if encroaches into the neural canal. This study is organised to evaluate the efficacy and safety of β-blockers drugs in adults with spinal hemangioma.

Timeline

Start
2021-12
Primary completion
2022-12
Completion
2023-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atenolol Other / unclassified
Comparator Propranolol Small molecule